Clinical trials
Phase 2 Overweight trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 10 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 6 |
| Not yet recruiting | 4 |
| Recruiting | 4 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Minwei Biotechnology Co., Ltd | 5 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Beijing QL Biopharmaceutical Co.,Ltd | 2 |
| BrightGene Bio-Medical Technology Co., Ltd. | 2 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2 |
| The United Bio-Technology (Hengqin) Co., Ltd. | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 1 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 34 |
| Obesity | 33 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetes Mellitus | 1 |
| Endometrial Hyperplasia | 1 |
| Endometrial Neoplasms | 1 |
| Insulin Resistance | 1 |
| Metabolic Syndrome | 1 |
| Prediabetic State | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.